Enterprise AI platform expands across diverse industry use cases Institutional participation shows active positioning shifts in shares Earnings release reflects revenue pressure and margin challenges ...
Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results